$SNDX #SNDX announced preclinical and initial clinical data for SNDX-5613 in adults with relapse/refractory leukemias... https://t.co/XwiU6nkAhO
@MightySoldiers 

#daytrader #daytrading #stockmarket #stocks #charts #trendspider #benzingapro 

https://t.co/Uw9Qsppdt9 https://t.co/oVGqLjZqP3